Efficacy and tolerance of the Plitidepsine in patients with a dedifferencie Liposarcoma (DLPS) advanced, non-operable or metastatic in relapse/refractory: A multi-center exploratory phase II.

Trial Profile

Efficacy and tolerance of the Plitidepsine in patients with a dedifferencie Liposarcoma (DLPS) advanced, non-operable or metastatic in relapse/refractory: A multi-center exploratory phase II.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2012

At a glance

  • Drugs Plitidepsin (Primary)
  • Indications Liposarcoma
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top